V Square Quantitative Management LLC cut its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,002 shares of the semiconductor company’s stock after selling 28 shares during the quarter. V Square Quantitative Management LLC’s holdings in Synopsys were worth $1,457,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Compagnie Lombard Odier SCmA raised its stake in shares of Synopsys by 1.1% during the fourth quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company’s stock valued at $898,000 after acquiring an additional 20 shares in the last quarter. Vontobel Holding Ltd. grew its holdings in Synopsys by 10.0% in the fourth quarter. Vontobel Holding Ltd. now owns 1,062,142 shares of the semiconductor company’s stock worth $515,521,000 after purchasing an additional 96,886 shares during the last quarter. Bogart Wealth LLC acquired a new position in shares of Synopsys in the 4th quarter valued at $6,126,000. Catalyst Financial Partners LLC increased its position in shares of Synopsys by 9.4% in the 4th quarter. Catalyst Financial Partners LLC now owns 467 shares of the semiconductor company’s stock valued at $227,000 after acquiring an additional 40 shares during the period. Finally, Avestar Capital LLC increased its position in shares of Synopsys by 24.0% in the 4th quarter. Avestar Capital LLC now owns 1,924 shares of the semiconductor company’s stock valued at $934,000 after acquiring an additional 372 shares during the period. 85.47% of the stock is owned by institutional investors.
Synopsys Stock Up 3.6 %
Shares of NASDAQ:SNPS opened at $528.29 on Friday. The company has a market cap of $81.66 billion, a PE ratio of 36.38, a P/E/G ratio of 3.49 and a beta of 1.12. The company’s 50-day moving average price is $510.41 and its 200 day moving average price is $518.16. Synopsys, Inc. has a fifty-two week low of $457.52 and a fifty-two week high of $629.38.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on Synopsys
Insider Buying and Selling at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares of the company’s stock, valued at $738,774.60. The trade was a 93.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.66% of the stock is owned by corporate insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Stock Market Sectors: What Are They and How Many Are There?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Pros And Cons Of Monthly Dividend Stocks
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Top Stocks Investing in 5G Technology
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.